market, which reached $1.9 billion in sales in 2011, will also be driven by the adoption of new technologies such as double-balloon and ultrasound endoscopes. Growth is also expected in gastrointestinal hemostasis devices, which are used to repair gastrointestinal hemorrhaging; ligation clips, which are less expensive and can be more effective than alternative therapies; and anti-reflux procedures, which are designed to treat gastroesophageal reflux disease. Anti-reflux procedures are expected to increase almost seven-fold by 2018 in the U.S.
Related Articles on Gastroenterology:
KY’s Jennie Stuart ASC Celebrates 5th Anniversary, Adds Barrett’s Esophagus Treatment
NY’s Richmond University Medical Center Opens $7M Ambulatory Center, Endoscopy Suite
Guthrie Health Opens $1.8M Endocrine and Bariatric Center in Pennsylvania
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
